This is a Validated Antibody Database (VAD) review about rat Cdc42bpb, based on 2 published articles (read how Labome selects the articles), using Cdc42bpb antibody in all methods. It is aimed to help Labome visitors find the most suited Cdc42bpb antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cdc42bpb synonym: serine/threonine-protein kinase MRCK beta; CDC42 binding protein kinase beta (DMPK-like); Cdc42-binding protein kinase beta; DMPK-like beta; MRCK beta; myotonic dystrophy kinase-related CDC42-binding kinase beta; myotonic dystrophy protein kinase-like beta

Knockout validation
Abnova
mouse monoclonal (2F4)
  • western blot knockout validation; human; loading ...; fig s4a
Abnova Cdc42bpb antibody (Abnova, H00009578-M03) was used in western blot knockout validation on human samples (fig s4a). Cancer Res (2018) ncbi
Santa Cruz Biotechnology
mouse monoclonal (C-12)
  • western blot knockout validation; mouse; loading ...; fig 7f
Santa Cruz Biotechnology Cdc42bpb antibody (Santa, sc-374597) was used in western blot knockout validation on mouse samples (fig 7f). J Biol Chem (2018) ncbi
Santa Cruz Biotechnology
mouse monoclonal (C-12)
  • western blot knockout validation; mouse; loading ...; fig 7f
Santa Cruz Biotechnology Cdc42bpb antibody (Santa, sc-374597) was used in western blot knockout validation on mouse samples (fig 7f). J Biol Chem (2018) ncbi
Abnova
mouse monoclonal (2F4)
  • western blot knockout validation; human; loading ...; fig s4a
Abnova Cdc42bpb antibody (Abnova, H00009578-M03) was used in western blot knockout validation on human samples (fig s4a). Cancer Res (2018) ncbi
Articles Reviewed
  1. Ge J, Burnier L, Adamopoulou M, Kwa M, Schaks M, Rottner K, et al. RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells. J Biol Chem. 2018;293:9358-9369 pubmed publisher
  2. Unbekandt M, Belshaw S, Bower J, Clarke M, Cordes J, Crighton D, et al. Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer. Cancer Res. 2018;78:2096-2114 pubmed publisher